Table 2.

Clinical utility of LncRNA.

Clinical utility	Model	Expression	LncRNA	Ref.
Biomarkers	AMI	Up	RP11-68I3.11, AC068831.6	[99]
		Up	LOC145474, LOC100129518, BRE-AS1, MIR22HG, MIR3945HG, ATP2B1-AS1, CATIPAS1, LINC00528	[100]
		Up	LIPCAR	[102]
		Up	UCA1 (72–96 h after onset of AMI)	[103]
		Up	KCNQ1OT1	[104]
		Up	CHAST	[105]
		Up	H19, MIAT, MALAT1	[106]
		Up	CDR1AS	[94]
		Down	RP11-133L14.5, PAX8-AS1, RP11-259K15.2, RP11-203M5.8, LINC01254	[99]
		Down	WDR86-AS1, A2M-AS1, and LINC00612	[100]
		Down	HOTAIR	[101]
		Down	UCA1 (early stage of AMI)	[103]
		Down	ANRIL	[104]
		Down	ZFAS1	[94]
	CAD	Up	H19	[107–108]
		Up	LIPCAR	[107]
		Up	ENST00000444488.1	[109]
		Up	OTTHUMT00000387022	[110]
		Down	uc010yfd.1	[109]
Therapy	Mice	Up	MDRL	[88]
		Up	CARL	[87]
		Down	APF	[52]
		Down	Meg3	[112]
		Down	NEAT1	[33]
		Down	H19	[77]
		Down	MALAT1	[29]
		Down	NRF	[59]
		Down	Mirt1	[78]
		Down	ZFAS1	[95]
	Rat	Up	HOTAIR	[113]
		Down	Mirt1	[79]
		Down	ZFAS1	[114]